The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lamkhioued, B.
Right arrow Articles by Renzi, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamkhioued, B.
Right arrow Articles by Renzi, P. M.
The Journal of Immunology, 2003, 170: 537-547.
Copyright © 2003 by The American Association of Immunologists

The CCR3 Receptor Is Involved in Eosinophil Differentiation and Is Up-Regulated by Th2 Cytokines in CD34+ Progenitor Cells1

Bouchaib Lamkhioued2,*,{dagger}, Soussi Gounni Abdelilah{dagger}, Qutayba Hamid{dagger}, Nabil Mansour{ddagger}, Guy Delespesse* and Paolo M. Renzi*

* Centre Hospitalier de l’Universite de Montreal, Research Center, Notre Dame Hospital, University of Montreal, {dagger} Meakins-Christie Laboratories and Departments of Medicine and Pathology, McGill University, and {ddagger} Charles le Moyne Hospital, Montreal, Quebec, Canada

The involvement of chemokines in eosinophil recruitment during inflammation and allergic reactions is well established. However, a functional role for chemokines in eosinophil differentiation has not been investigated. Using in situ RT-PCR, immunostaining, and flow cytometric analysis, we report that human CD34+ cord blood progenitor cells contain CCR3 mRNA and protein. Activation of CD34+ progenitor cells under conditions that promote Th2 type differentiation up-regulated surface expression of the CCR3. In contrast, activation with IL-12 and IFN-{gamma} resulted in a significant decrease in the expression of CCR3. Eotaxin induced Ca2+ mobilization in CD34+ progenitor cells, which could explain the in vitro and in vivo chemotactic responsiveness to eotaxin. We also found that eotaxin induced the differentiation of eosinophils from cord blood CD34+ progenitor cells. The largest number of mature eosinophils was found in cultures containing eotaxin and IL-5. The addition of neutralizing anti-IL-3, anti-IL-5, and anti-GM-CSF Abs to culture medium demonstrated that the differentiation of eosinophils in the presence of eotaxin was IL-3-, IL-5-, and GM-CSF-independent. These results could explain how CD34+ progenitor cells accumulate and persist in the airways and peripheral blood of patients with asthma and highlight an alternative mechanism by which blood and tissue eosinophilia might occur in the absence of IL-5.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Bonaros, H. Sondermejer, M. Schuster, R. Rauf, S.F. Wang, T. Seki, D. Skerrett, S. Itescu, and A.A. Kocher
CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair.
J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 1044 - 1053.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. M. Gauvreau, L. P. Boulet, D. W. Cockcroft, A. Baatjes, J. Cote, F. Deschesnes, B. Davis, T. Strinich, K. Howie, M. Duong, et al.
Antisense Therapy against CCR3 and the Common Beta Chain Attenuates Allergen-induced Eosinophilic Responses
Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 952 - 958.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. B. Rookmaaker, M. C. Verhaar, H. C. de Boer, R. Goldschmeding, J. A. Joles, H. A. Koomans, H.-J. Grone, and T. J. Rabelink
Met-RANTES reduces endothelial progenitor cell homing to activated (glomerular) endothelium in vitro and in vivo
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F624 - F630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. S. Gounni
The high-affinity IgE receptor (Fc{epsilon}RI): a critical regulator of airway smooth muscle cells?
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L312 - L321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Huaux, M. Gharaee-Kermani, T. Liu, V. Morel, B. McGarry, M. Ullenbruch, S. L. Kunkel, J. Wang, Z. Xing, and S. H. Phan
Role of Eotaxin-1 (CCL11) and CC Chemokine Receptor 3 (CCR3) in Bleomycin-Induced Lung Injury and Fibrosis
Am. J. Pathol., December 1, 2005; 167(6): 1485 - 1496.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. S. Gounni, V. Wellemans, J. Yang, F. Bellesort, K. Kassiri, S. Gangloff, M. Guenounou, A. J. Halayko, Q. Hamid, and B. Lamkhioued
Human Airway Smooth Muscle Cells Express the High Affinity Receptor for IgE (Fc{epsilon}RI): A Critical Role of Fc{epsilon}RI in Human Airway Smooth Muscle Cell Function
J. Immunol., August 15, 2005; 175(4): 2613 - 2621.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Joubert, S. Lajoie-Kadoch, I. Labonte, A. S. Gounni, K. Maghni, V. Wellemans, J. Chakir, M. Laviolette, Q. Hamid, and B. Lamkhioued
CCR3 Expression and Function in Asthmatic Airway Smooth Muscle Cells
J. Immunol., August 15, 2005; 175(4): 2702 - 2708.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. G. Boot, M. Verhoek, M. de Fost, C. E. M. Hollak, M. Maas, B. Bleijlevens, M. J. van Breemen, M. van Meurs, L. A. Boven, J. D. Laman, et al.
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention
Blood, January 1, 2004; 103(1): 33 - 39.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.